Ang IV significantly reduced RBF and CBF also when administered intrarenally at subpressor doses

CrossRef Impact of epicardial adipose tissue volume and hypertension on left ventricular hypertrophy in preclinical heart failure patients with metabolic syndrome Junshi Xie, Zhiqiang Liu, Anqi Cheng, Lei Gao BMC Cardiovascular Disorders.2025;[Epub] CrossRef Cardiac magnetic resonance quantification of epicardial adipose tissue identifies subclinical cardiac dysfunction in asymptomatic obesity: A multicenter crosssectional study Xu Wang, Hang Zhao, Jiang Yue, Yezi Chai, Jing Ma, Meng Jiang, Jun Pu VIEW.2025;[Epub] CrossRef Advances in Molecular Mechanisms and Precision Interventions of Cardiovascular Injuries Related to Glucose and Lipid Metabolism Disorders Li Wu, Jiyao Xu, Chenxia Wu, Minyan Wang, Tingting Chen, Conghua Ji, Wei Mao Reviews in Cardiovascular Medicine.2025;[Epub] CrossRef Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients Liqin Cui, Min Yang Lipids in Health and Disease.2025;[Epub] CrossRef New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review Jorge E

Animal research provides valuable mechanistic understanding but doesn't guarantee identical effects or safety in humans
Runners who ignore early symptoms often end up sidelined for months